Related Experiment Video
Updated: May 11, 2026

Visualizing Impairment of the Endothelial and Glial Barriers of the Neurovascular Unit during Experimental Autoimmune Encephalomyelitis In Vivo
Published on: March 26, 2019
TRPV1 gates tissue access and sustains pathogenicity in autoimmune encephalitis
Geoffrey Paltser1, Xue Jun Liu, Jason Yantha
1Neuroscience and Mental Health Program, Research Institute, The Hospital for Sick Children, Toronto, Ontario, Canada.
Transient Receptor Potential Vanilloid-1 (TRPV1) influences multiple sclerosis (MS) progression by affecting central nervous system infiltration. Targeting TRPV1 may offer new therapeutic strategies for MS.
Area of Science:
- Neuroscience
- Immunology
- Genetics
Background:
- Multiple sclerosis (MS) is a chronic, progressive demyelinating disease with unmet therapeutic needs and an unclear pathoetiology.
- The role of specific ion channels, like Transient Receptor Potential Vanilloid-1 (TRPV1), in MS pathogenesis is not fully understood.
Purpose of the Study:
- To investigate the role of TRPV1 in the severity and progression of experimental autoimmune encephalomyelitis (EAE), a mouse model for MS.
- To explore the association between TRPV1 and primary progressive MS in human patients.
Main Methods:
- Utilized TRPV1 knockout (TRPV1-/-) mice to assess EAE development and progression.
- Analyzed central nervous system (CNS) immune cell infiltration and peripheral T cell responses.
- Examined the association of a specific TRPV1 single nucleotide polymorphism (SNP), rs877610, with primary progressive MS in human patients.
Main Results:
- TRPV1-/- mice were protected from EAE, exhibiting increased survival due to reduced CNS infiltration.
- Peripheral T cell autoreactivity and pathogenicity were comparable between TRPV1-sufficient and TRPV1-deficient mice.
- The TRPV1+ neurovascular complex at the blood-CNS barrier facilitated pathogenic lymphocyte invasion, independent of TRPV1-dependent neuropeptides.
- A significant risk association was found between the rs877610 TRPV1 SNP and primary progressive MS.
Conclusions:
- TRPV1 acts as a critical disease modifier in EAE, influencing disease severity and progression.
- TRPV1 is implicated in the invasion of pathogenic lymphocytes into the CNS.
- The rs877610 TRPV1 SNP may serve as a predictor for severe MS disease course.
- TRPV1 represents a potential novel therapeutic target for multiple sclerosis.
Related Concept Videos
Encephalitis ll: Pathophysiology
Encephalitis l: Introduction
Arboviral Encephalitis
Viral Meningitis
Bacterial Meningitis II: Pathophysiology

